Antibiotics increase susceptibility to CDI by disrupting cross-talk between the microbiome and mucosal immune system, reducing IL-33 and IL-25 expression and creating a pro-inflammatory environment that favors CDI (25). The gene discussed is IL25; the disease is clostridium difficile infection.